HomeCompareNETZ vs JNJ

NETZ vs JNJ: Dividend Comparison 2026

NETZ yields 0.21% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $53.00 in total portfolio value· pulled ahead in Year 10
10 years
NETZ
NETZ
● Live price
0.21%
Share price
$78.17
Annual div
$0.17
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$21.66
Full NETZ calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — NETZ vs JNJ

📍 JNJ pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNETZJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NETZ + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NETZ pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NETZ
Annual income on $10K today (after 15% tax)
$18.16/yr
After 10yr DRIP, annual income (after tax)
$18.41/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $685.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NETZ + JNJ for your $10,000?

NETZ: 50%JNJ: 50%
100% JNJ50/50100% NETZ
Portfolio after 10yr
$20.0K
Annual income
$424.72/yr
Blended yield
2.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NETZ
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NETZ buys
0
JNJ buys
0
No recent congressional trades found for NETZ or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNETZJNJ
Forward yield0.21%3.36%
Annual dividend / share$0.17$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.0K$20.0K
Annual income after 10y$21.66$827.78
Total dividends collected$215.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NETZ vs JNJ ($10,000, DRIP)

YearNETZ PortfolioNETZ Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,721$21.36$10,676$355.77+$45.00NETZ
2$11,493$21.41$11,407$389.39+$86.00NETZ
3$12,319$21.45$12,198$426.53+$121.00NETZ
4$13,203$21.48$13,056$467.62+$147.00NETZ
5$14,149$21.52$13,987$513.12+$162.00NETZ
6$15,161$21.55$14,998$563.56+$163.00NETZ
7$16,244$21.58$16,098$619.52+$146.00NETZ
8$17,402$21.61$17,295$681.69+$107.00NETZ
9$18,642$21.64$18,599$750.82+$43.00NETZ
10← crossover$19,969$21.66$20,022$827.78$53.00JNJ

NETZ vs JNJ: Complete Analysis 2026

NETZStock

The fund is an actively-managed ETF that seeks to invest in companies that are creating value by transforming themselves and others to meet the growing demands of climate change. The Advisor intends to initially invest primarily in U.S. listed equity and American Depositary Receipts ("ADRs") securities of companies relevant to its investment theme and over time may invest in non-U.S. listed securities as market and investment opportunities change. The fund's investments may include micro-, small-, medium- and large-capitalization companies. It is non-diversified.

Full NETZ Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this NETZ vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NETZ vs SCHDNETZ vs JEPINETZ vs ONETZ vs KONETZ vs MAINNETZ vs ABBVNETZ vs MRKNETZ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.